지난행사

AI Pharma Korea
Conference 2019
일시 : 2019년 11월 7일(목)
장소 : 르 메르디앙 서울, 다빈치볼룸(LL)

행사개요

행 사 명 AI Pharma Korea Conference 2019
일시 및 장소 2019년 11월 7일(목) 9:00~16:20, 르메르디앙서울, 다빈치볼룸(LL)
주최
주관
후원
발표업체

프로그램

시 간 내 용 발표자
09:00~10:00 기자간담회
09:00~10:00 등록
10:00~10:15 개회사 및 축사
“Applying AI to Drug Discovery, now and future”
Session 1 : Current status and Future direction Chair: Dongho Lee, M.D., Ph.D (President of Korea AI center for Drug
discovery and development at KPBMA)
10:15∼10:45 Harnessing Applied AI and Analytics to reshape drug development AstraZeneca Mishal Patel (Senior Director & Head of Health Informatics)
10:45∼11:15 Decentralized Drug Development -
Accelerating Time to Market in Data-Driven Marketplaces		 Molecule Protocol Paul Kohlhaas (Founder & CEO)
11:15∼11:45 Opinion on the AI-based New Drug Development from the IT Guy Perspective SK holdings Seonee Nam (General Manager/SK Healthcare group)
11:45∼13:00 Luncheon
Session 2 : Beyond traditional computational approach Chair: Dongsup Kim, Ph.D (Department of Bio and Brain Engineering, KAIST)
13:00∼13:30 Artificial Intelligence in Drug Design - Opportunities and Pitfalls University of Cambridge Andreas Bender (Group leader for Data-Driven Drug Discovery at the Centre for Molecular Informatics)
13:30∼14:00 Accelerating Drug Discovery with Advanced Computational Modeling and Deep Learning Schrödinger Byungchan Kim (Principal scientist)
14:00∼14:30 Deep generative autopilot for the real-world design of novel lead compounds Standigm Sangok Song (Chief Transformation Officer & Cofounder)
14:30∼14:50 Break time
Session 3 : The Practical Impact of AI in Drug Discovery So Far Chair: Jaewoo Kang, Ph.D (Department of Computer Science and Engineering/Korea University)
14:50∼15:20 How AI can Design Multi-Targeted Drug-Like Molecules Cyclica Naheed Kurji (CEO)
15:20∼15:50 Computational Drug Design Engine SCULPTTM meets AI -
Powerful Drug Discovery Engine for Hard to Drug Targets		 A2A Pharmaceuticals Chaemin Lim (CSO/Chief Scientific Officer)
15:50∼16:20

AI-based early stage drug discovery: from hit to lead

 KAIST Woo Youn Kim (Professor, Department of Chemistry)
16:20 폐회